Fractyl Health, INC Form 4 insider transactions

Director Ajay Royan purchased 23,000 shares of Fractyl Health, Inc. (GUTS) at an average price of $0.852 per share.

Director William Bradley acquired 68,493 shares of Fractyl Health (GUTS) and received a stock option grant for 22,500 shares.

Director Samuel Conaway was granted 22,500 stock options as part of Fractyl Health's non-employee director compensation policy.

Director Ajay Royan was granted 22,500 stock options as part of Fractyl Health's non-employee director compensation policy.

Director Christopher Charles Thompson was granted 22,500 stock options as part of Fractyl Health's non-employee director compensation policy.

Director Marc Elia was granted 22,500 stock options as part of Fractyl Health's non-employee director compensation policy.

Director Kelly Ann Barnes was granted 22,500 stock options as part of Fractyl Health's non-employee director compensation policy.

Director Clive Meanwell was granted 22,500 stock options as part of Fractyl Health's non-employee director compensation policy.

Director Ian Sheffield acquired 35,000 shares of Fractyl Health, Inc. (GUTS) and received a stock option grant for 22,500 shares.

CEO Harith Rajagopalan purchased 25,000 shares of Fractyl Health common stock in an open market transaction.

Fractyl Health CFO Lara Smith Weber purchased 20,000 shares of common stock in an open market transaction.

FRACTYL HEALTH, INC. Chief Financial Officer Lara Smith Weber was granted 1,036,800 stock options with an exercise price of $2, vesting over four years.

Fractyl Health's General Counsel, Sarah Toomey, was granted 743,913 stock options with an exercise price of $2.24, vesting over three years.

Fractyl Health's President and Chief Product Officer, Jay David Caplan, was granted 845,226 stock options with an exercise price of $2.24, vesting over three years.

FRACTYL HEALTH, INC. CEO Harith Rajagopalan was granted 2,486,302 stock options with an exercise price of $2.24, vesting over three years.

Fractyl Health's CEO, Harith Rajagopalan, acquired 10,416 shares of common stock at $1.92 per share through a private placement.

Fractyl Health, Inc. director Christopher Charles Thompson was granted 45,000 stock options as part of his board compensation.

Fractyl Health, Inc. director Ian Sheffield received 45,000 stock options with a $0.9767 exercise price as part of his board appointment.

Amy W. Schulman, a Director at Fractyl Health, Inc., was granted 22,500 stock options as compensation for her board service, with an exercise price of $2.27 per share.

Fractyl Health, Inc. director Marc Elia was granted 22,500 stock options with an exercise price of $2.27 as part of his compensation for board service.

Fractyl Health, Inc. director Clive Meanwell was granted 22,500 stock options with an exercise price of $2.27 as part of his compensation for board service.

Fractyl Health, Inc. Director William Bradley was granted 22,500 stock options with an exercise price of $2.27, with the grant effective date scheduled for June 11, 2025, as part of his non-employee director compensation.

Fractyl Health, Inc. Director Kelly Ann Barnes was granted 22,500 stock options as compensation for her board service, exercisable at $2.27 per share.

Fractyl Health, Inc. (GUTS) has reported that Director and 10% Owner Ajay Royan was granted 22,500 stock options as compensation for his board service.

Fractyl Health, Inc. Director Samuel Conaway was granted 22,500 stock options as compensation, aligning his interests with the company's long-term performance.

Samuel Conaway, a director of FRACTYL HEALTH, INC., files an amended Form 4 to correct a previous filing that mistakenly reported a purchase of common stock.

Director Royan Ajay reports purchasing 17,901 shares of Fractyl Health at a weighted average price of $1.2837 on March 14, 2025.

Director Kelly Ann Barnes reports the acquisition of 31,000 shares of FRACTYL HEALTH, INC. common stock at a price of $1.2971 per share on March 14, 2025.

Director Amy W. Schulman reported the purchase of 8,550 shares of FRACTYL HEALTH, INC. common stock at a weighted average price of $1.1654 on March 13, 2025.

Director William Bradley purchased 16,129 shares of FRACTYL HEALTH at an average price of $1.2622 on March 13, 2025.